SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. Logo

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.

A contract research organization providing preclinical and clinical services for medical industries.

2395 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
鹿児島市宮之浦町2438番地
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Shin Nippon Biomedical Laboratories, Ltd. (SNBL), established in 1957 as Japan's pioneering contract research organization (CRO), offers comprehensive drug development support services. The company specializes in preclinical and nonclinical safety studies, translational research, and clinical trial services for the pharmaceutical, medical device, and regenerative medicine industries. A key area of innovation includes the research and development of its proprietary nasal delivery system (NDS), the μco™ System. SNBL's mission is to free patients from suffering by supporting the creation of advanced medical technologies and novel pharmaceuticals.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-30 08:58
Post-Annual General Meeting Information
臨時報告書
Japanese 24.7 KB
2025-06-27 07:46
Regulatory News Service
確認書
Japanese 8.2 KB
2025-06-27 07:40
Regulatory News Service
内部統制報告書-第52期(2024/04/01-2025/03/31)
Japanese 23.5 KB
2025-06-27 07:32
Annual Report
有価証券報告書-第52期(2024/04/01-2025/03/31)
Japanese 3.0 MB
2024-11-06 04:17
Report Publication Announcement
確認書
Japanese 10.8 KB
2024-11-06 04:11
Interim Report
半期報告書-第52期(2024/04/01-2025/03/31)
Japanese 253.7 KB
2024-06-26 04:52
Regulatory News Service
臨時報告書
Japanese 24.6 KB
2024-06-25 07:06
Regulatory News Service
確認書
Japanese 8.2 KB
2024-06-25 06:57
Governance Information
内部統制報告書-第51期(2023/04/01-2024/03/31)
Japanese 22.5 KB
2024-06-25 06:38
Annual Report
有価証券報告書-第51期(2023/04/01-2024/03/31)
Japanese 3.2 MB
2024-02-02 03:40
Report Publication Announcement
確認書
Japanese 10.8 KB
2024-02-02 03:39
Quarterly Report
四半期報告書-第51期第3四半期(2023/10/01-2023/12/31)
Japanese 203.9 KB
2023-11-07 07:18
Report Publication Announcement
確認書
Japanese 10.8 KB
2023-11-07 07:08
Quarterly Report
四半期報告書-第51期第2四半期(2023/07/01-2023/09/30)
Japanese 248.6 KB
2023-08-02 05:34
Report Publication Announcement
確認書
Japanese 10.8 KB

Automate Your Workflow. Get a real-time feed of all SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766

Talk to a Data Expert

Have a question? We'll get back to you promptly.